140 related articles for article (PubMed ID: 38251849)
1. Mn
Ling K; Zheng J; Jiang X; Huang W; Mai Y; Liao C; Fan S; Bu J; Li R; Zeng B; Zheng Q; Huang R; Li Z; Wong NK; Jiang H
ACS Nano; 2024 Jan; 18(4):2841-2860. PubMed ID: 38251849
[TBL] [Abstract][Full Text] [Related]
2. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
[TBL] [Abstract][Full Text] [Related]
3. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Calcium-Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment.
Luo G; Li X; Lin J; Ge G; Fang J; Song W; Xiao GG; Zhang B; Peng X; Duo Y; Tang BZ
ACS Nano; 2023 Aug; 17(16):15449-15465. PubMed ID: 37530575
[TBL] [Abstract][Full Text] [Related]
5. Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy.
Zhang H; Wang Z; Wang S; Zhang J; Qiu L; Chen J
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126998. PubMed ID: 37729981
[TBL] [Abstract][Full Text] [Related]
6. Glycogen for lysosome-targeted CpG ODNs delivery and enhanced cancer immunotherapy.
Zhang H; Lai L; Wang Z; Zhang J; Zhou J; Nie Y; Chen J
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128536. PubMed ID: 38061522
[TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment-Responsive Nanoparticles Amplifying STING Signaling Pathway for Cancer Immunotherapy.
Liu D; Liang S; Ma K; Meng QF; Li X; Wei J; Zhou M; Yun K; Pan Y; Rao L; Chen X; Wang Z
Adv Mater; 2024 Feb; 36(6):e2304845. PubMed ID: 37723642
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice.
Munakata L; Tanimoto Y; Osa A; Meng J; Haseda Y; Naito Y; Machiyama H; Kumanogoh A; Omata D; Maruyama K; Yoshioka Y; Okada Y; Koyama S; Suzuki R; Aoshi T
J Control Release; 2019 Nov; 313():106-119. PubMed ID: 31629036
[TBL] [Abstract][Full Text] [Related]
9. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy.
Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R
Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080
[TBL] [Abstract][Full Text] [Related]
10. Biomineralized MnO
Deng Z; Xi M; Zhang C; Wu X; Li Q; Wang C; Fang H; Sun G; Zhang Y; Yang G; Liu Z
ACS Nano; 2023 Mar; 17(5):4495-4506. PubMed ID: 36848115
[TBL] [Abstract][Full Text] [Related]
11. Yeast β-D-glucan functionalized graphene oxide for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced antitumor immunity.
Cheng T; Yan T; Wu J; Wang Q; Zhang H
Int J Biol Macromol; 2023 Apr; 234():123432. PubMed ID: 36716835
[TBL] [Abstract][Full Text] [Related]
12. Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade.
Li T; Hua C; Yue W; Wu J; Lv X; Wei Q; Zhu S; Zang G; Cui J; Liu YJ; Chen J
Pharmacol Res; 2020 Nov; 161():105293. PubMed ID: 33176206
[TBL] [Abstract][Full Text] [Related]
13. Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy.
Zhou M; Liang S; Liu D; Ma K; Yun K; Yao J; Peng Y; Hai L; Zhang Q; Wang Z
Nano Lett; 2023 Nov; 23(22):10350-10359. PubMed ID: 37930173
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
15. Mn
Jiang H; Xia Q; Zheng J; Bu J; Li R; Cai Z; Ling K
Biosens Bioelectron; 2022 Nov; 216():114622. PubMed ID: 35973273
[TBL] [Abstract][Full Text] [Related]
16. Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth.
Shan H; Dou W; Zhang Y; Qi M
Nanoscale; 2020 Nov; 12(43):22268-22280. PubMed ID: 33146206
[TBL] [Abstract][Full Text] [Related]
17. NIR responsive nanoenzymes via photothermal ablation and hypoxia reversal to potentiate the STING-dependent innate antitumor immunity.
Li Q; Yang M; Sun X; Wang Q; Yu B; Gong A; Zhang M; Du F
Mater Today Bio; 2023 Apr; 19():100566. PubMed ID: 36816600
[TBL] [Abstract][Full Text] [Related]
18. Small EV-based delivery of CpG ODNs for melanoma postsurgical immunotherapy.
Lu Y; Ye H; Zhao J; Wang K; Fan X; Lu Q; Cao L; Wan B; Liu F; Sun F; Chen X; He Z; Liu H; Sun J
J Control Release; 2023 Nov; 363():484-495. PubMed ID: 37778468
[TBL] [Abstract][Full Text] [Related]
19. Combination of Metal-Phenolic Network-Based Immunoactive Nanoparticles and Bipolar Irreversible Electroporation for Effective Cancer Immunotherapy.
Han JH; Shin HE; Lee J; Kang JM; Park JH; Park CG; Han DK; Kim IH; Park W
Small; 2022 Jun; 18(25):e2200316. PubMed ID: 35570584
[TBL] [Abstract][Full Text] [Related]
20. Dual-Modality Imaging-Guided Manganese-Based Nanotransformer for Enhanced Gas-Photothermal Therapy Combined Immunotherapeutic Strategy Against Triple-Negative Breast Cancer.
Guan X; Zeng N; Zhao Y; Huang X; Lai S; Shen G; Zhang W; Wang N; Yao W; Guo Y; Yang R; Wang Z; Jiang X
Small; 2024 May; 20(22):e2307961. PubMed ID: 38126911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
